Orio Therapeutics

Switzerland
Monthey, Valais, Switzerland, 1870

Company profile

Orio Therapeutics company profile

Orio Therapeutics is a biotechnology research company that is redefining regeneration by modifying therapeutic proteins to optimize distribution through controlled localization. The company offers therapeutic solutions for patients suffering from myocardial infarction.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2023-01-01, Year

Headquarters

Postal code
1870
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
5
Total equity funding
$552,097
Last funding
Convertible Note / $118,113 / 2024-09-10
Last equity funding
Pre Seed / $552,097
Investors
2
Lead investors
1
Founders
2
Articles
8

Founders and investors

Founders

Mikaël MartinoZiad Julier

Lead investors

Venture Kick

Investors

KickfundVenture Kick